SYNLAB AG |
Market Closed -
Other stock markets
|
After market 11:51:40 am | |||
| 10.36 EUR | +0.58% |
|
10.34 | -0.19% |
| May. 08 | Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Laboratory chain Synlab starts the year with lower revenue | DP |
ETFs positioned on SYNLAB AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | ||
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% | ||
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +3.91% | - | |
| 0.00% | 146 M€ | -2.22% | - | |
| 0.00% | 25 M€ | 0.00% | - | |
| 0.00% | 1 M€ | 0.00% | - | |
| 0.00% | 29 M€ | -2.00% | - |
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
2024-05-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.3
EUR
Average target price
14.5
EUR
Spread / Average Target
+40.78%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.28% | 2.45B | |
| -16.80% | 8.79B | |
| +65.11% | 4.19B | |
| -4.03% | 2.48B | |
| -42.54% | 2.29B | |
| -6.18% | 1.97B | |
| -20.18% | 1.56B | |
| -41.24% | 1.22B | |
| +10.26% | 1.13B | |
| +18.74% | 933M |
- Stock Market
- Equities
- SYAB Stock
- Funds and ETFs SYNLAB AG